Thousand Oaks-based Atara Biotherapeutics announced June 17 that it will be undergoing a 1-for-25 reverse stock split which will become effective at 12:01 a.m. June 20. A reverse stock split consolidates the number of existing shares of stock into fewer, higher-priced shares. For example, Atara shares closed at 42 cents per share on June 16, dropping 16% over the course…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
